• FirefoxInstall the new Firefox »
  •  Dow Down 1.11% Nasdaq Down 0.94%

    Curis, Inc. (CRIS)

    -NasdaqGM
    2.40 Down 0.10(4.00%) Mar 31, 4:00PM EDT
    Add to Portfolio
    Prev Close:2.50
    Open:2.46
    Bid:2.10 x 2000
    Ask:3.49 x 500
    1y Target Est:5.00
    Beta:1.6
    Earnings Date:May 6 - May 11 (Est.)
    Day's Range:2.29 - 2.50
    52wk Range:1.09 - 3.50
    Volume:1,513,988
    Avg Vol (3m):1,542,290
    Market Cap:247.63M
    P/E (ttm):N/A
    EPS (ttm):-0.22
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CRISDown 4.00%247.63M
    EXELDown 4.81%503.45M
    INFIDown 2.37%683.90M
    PFEDown 0.60%213.22B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):26.20
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.27
    Quarterly EPS Est (Mar-15) :-0.06
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers. The company develops CUDC-907, an oral small molecule inhibitor of histone deacetylase and phosphatidylinositol-3... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback